Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_assertion type Assertion NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_head.
- NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_assertion description "[We then studied sera from 70 CIDP patients, 35 Guillain-Barr� syndrome (GBS) patients, and 483 disease (amyotrophic lateral sclerosis, Alzheimer's disease, multiple sclerosis, diabetes, and other polyneuropathies) and normal controls for selective high-titer anti-beta-tubulin using ELISA methodology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_provenance.
- NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_assertion evidence source_evidence_literature NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_provenance.
- NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_assertion SIO_000772 8451001 NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_provenance.
- NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_assertion wasDerivedFrom befree-20140225 NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_provenance.
- NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_assertion wasGeneratedBy ECO_0000203 NP673051.RA9jAS7heeBwsc2goER4R8rar4ziJ5FWMA8H0_L0ZJAFk130_provenance.